Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Location
1100 Campus Road, Princeton, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 143 % -43.6%
Quick Ratio 58.3 % -34.6%
Debt-to-equity 199 % +27.5%
Return On Equity -38.5 % -9082%
Return On Assets -12.9 % -7763%
Operating Margin -29.3 % -1689%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.9M shares +0.94%
Entity Public Float 2.19B USD -32.8%
Common Stock, Value, Issued 923K USD +0.76%
Weighted Average Number of Shares Outstanding, Basic 76.8M shares +0.4%
Weighted Average Number of Shares Outstanding, Diluted 76.8M shares +0.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.64B USD +4.99%
Costs and Expenses 2.12B USD +38.3%
Operating Income (Loss) -481M USD -1768%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -545M USD -4475%
Income Tax Expense (Benefit) -49.9M USD -829%
Net Income (Loss) Attributable to Parent -495M USD -7469%
Earnings Per Share, Basic -6 USD/shares -7975%
Earnings Per Share, Diluted -6 USD/shares -7975%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 232M USD +7.92%
Accounts Receivable, after Allowance for Credit Loss, Current 262M USD +5.58%
Inventory, Net 489M USD +11.9%
Other Assets, Current 30.3M USD -39.8%
Assets, Current 1.14B USD +4.01%
Deferred Income Tax Assets, Net 110M USD +124%
Property, Plant and Equipment, Net 437M USD +11.9%
Operating Lease, Right-of-Use Asset 138M USD -5.57%
Intangible Assets, Net (Excluding Goodwill) 1.16B USD -4.08%
Goodwill 615M USD -44.9%
Other Assets, Noncurrent 42.2M USD -21.8%
Assets 3.65B USD -10.3%
Employee-related Liabilities, Current 75M USD -1.88%
Accrued Liabilities, Current 133M USD +0.7%
Contract with Customer, Liability, Current 11.3M USD +13.4%
Liabilities, Current 364M USD -60.1%
Contract with Customer, Liability, Noncurrent 11M USD +35.8%
Deferred Income Tax Liabilities, Net 58.3M USD -15.5%
Operating Lease, Liability, Noncurrent 161M USD -4.1%
Other Liabilities, Noncurrent 233M USD +22.9%
Liabilities 2.61B USD +2.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax -32M USD -28.7%
Retained Earnings (Accumulated Deficit) 425M USD -53.8%
Stockholders' Equity Attributable to Parent 1.04B USD -31.8%
Liabilities and Equity 3.65B USD -10.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.3M USD -171%
Net Cash Provided by (Used in) Financing Activities 35.4M USD -90.1%
Net Cash Provided by (Used in) Investing Activities -35.9M USD +33.4%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 92.3M shares +0.72%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.27M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 232M USD +7.92%
Deferred Tax Assets, Valuation Allowance 15.5M USD +24.2%
Deferred Tax Assets, Gross 240M USD +0.23%
Operating Lease, Liability 175M USD -4.42%
Payments to Acquire Property, Plant, and Equipment 28.9M USD +87%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -502M USD -1416%
Lessee, Operating Lease, Liability, to be Paid 262M USD -2.98%
Property, Plant and Equipment, Gross 803M USD +13.4%
Operating Lease, Liability, Current 13.8M USD -8.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.9M USD -3.23%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.6M USD -24.4%
Deferred Income Tax Expense (Benefit) -1.83M USD +35.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 87.3M USD +0.03%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.5M USD -6.28%
Deferred Tax Assets, Operating Loss Carryforwards 27.4M USD -4.96%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 826K USD +1.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.1M USD +3.76%
Operating Lease, Payments 5.89M USD +2.72%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 14.9M USD -27.7%
Deferred Tax Assets, Net of Valuation Allowance 225M USD -1.09%
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares